This invention relates to compounds of the formula I wherein R.sup.1-R.sup.8 and n are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

 
Web www.patentalert.com

< Vitamin E tocotrienols inhibition of intracellularly obligate pathogen Chlamydia and methods of use

< Dihydrobenzofuran derivatives and uses thereof

> Substituted quinazolinone compounds

> Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
~ 00237